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Gain and Loss of Function mutations in biological
chemical reaction networks: a mathematical model
with application to colorectal cancer cells
Sara Sommariva · Giacomo Caviglia ·
Michele Piana
Abstract This paper studies a system of Ordinary Differential Equations
modeling a chemical reaction network and derives from it a simulation tool
mimicking Loss of Function and Gain of Function mutations found in cancer
cells. More specifically, from a theoretical perspective, our approach focuses
on the determination of moiety conservation laws for the system and their
relation with the corresponding stoichiometric surfaces. Then we show that
Loss of Function mutations can be implemented in the model via modification
of the initial conditions in the system, while Gain of Function mutations can
be implemented by eliminating specific reactions. Finally, the model is utilized
to examine in detail the G1-S phase of a colorectal cancer cell.
Keywords Reaction kinetics - Synthetic cell biology - Loss of function mu-
tations - Gain of function mutations - Colorectal cancer cells - G1-S transition
point
1 Introduction
Signalling networks are Chemical Reaction Networks (CRNs) consisting of an
interconnected set of pathways, modeling the flow of chemical reactions initi-
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2 Sara Sommariva et al.
ated by information sensed from the environment through families of receptor
ligands (Jordan et al., 2000; Sever and Brugge, 2015; Tyson and Novak, 2008).
The reactions in the network follow the process of information transfer inside
cytosol down to the description of the activity of a few related transcription
factors (Karin and Smeal, 1992; Kohn et al., 2006). Similarly to what happens
for many networks of biological interest, a signaling network may comprise
hundreds of reacting chemical species and reactions.
Any CRN can be mapped into a system of ordinary differential equations
(ODEs) by following standard procedures (Feinberg, 1987; Yu and Craciun,
2018; Chellaboina et al., 2009) thus allowing for simulations of the kinetics
of the signaling process in the biologic case (see, e.g., Anderson et al. (2019);
Roy and Finley (2017)). In principle, the resulting mathematical model is ca-
pable of describing healthy physiologic states, and can be adapted to simulate
individual pathological conditions associated to mutations. Since most cancer
diseases result from an accumulation of a set of mutations (Stratton et al.,
2009; Levine et al., 2019), the numerical solution of this mathematical model
represents a convenient computational tool for the simulation of the mech-
anisms giving rise to a tumor. Further, this kind of models can typically be
tuned in order to mimic the effects of targeted therapies (Facchetti et al., 2012;
Levine, 2019) and drug resistance mechanisms (Eduati et al., 2017).
The present paper first realizes an analysis of the system of ODEs asso-
ciated to a CRN, characterized by a level of generality sufficient to provide
an efficient simulation tool. From a formal viewpoint, we apply mathematical
methods devised for the investigation of deterministic homogeneous chemical
reaction systems based on mass-action kinetics. However, in our approach a
crucial role is played by moiety conservation laws (CLs), which are essential
in the determination and interpretation of results (De Martino et al., 2014;
Shinar et al., 2009). Further, a geometric classification of equilibrium states
in terms of stoichiometric surfaces is discussed, together with their stability
properties.
From a more operating viewpoint, we define projection operators, which
map the system of ODE for physiologic conditions into the mutated system
which models Loss of Function (LoF) and Gain of Function (GoF) mutations
(Griffiths et al., 2005; Li et al., 2019). The model is built and made operative
in such a way that it can be modified almost straightforwardly by addition
or elimination of chemical reactions or chemical species, change in the values
of the rate constants in the formulation of mass-action laws, or change of the
initial conditions. As a consequence, the parameters values that have been
originally considered as fixed can be customized to fit the tumor data of a
specific patient.
As an application, we examine in detail the kinetics of a recently proposed
network which simulates how colorectal cancer (CRC) cells process informa-
tion from external growth factors and the related answer (Tortolina et al.,
2015). The network is focused on the G1-S transition point. In this transition
a newborn cell in the G1 phase of its cycle must pass the control of this check-
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point before starting the S phase of synthesis of new DNA (Tyson and Novak,
2008); indeed, this is the first necessary step towards proliferation.
The structure of the paper is as follows. Section 2 provides the mathemati-
cal background for the modeling of CRNs for cell signaling. Section 3 contains
the mathematical model describing LoF and GoF mutation processes. Section
4 is devoted to the application of the model to CRC cells. Our conclusions are
offered in Section 5.
2 Chemical reaction networks for cell signaling
We consider a CRN consisting of r reactions, denoted as Rj , j = 1, . . . , r, that
involve n well-mixed reacting species, denoted as Ai, i = 1, . . . , n. The network
is modeled as a dynamical system with state vector x = (x1, . . . , xn)
T ∈ Rn+,
where the upper T denotes transposition, R+ is the set of non-negative real
number, and the generic component xi is the molar concentration (nM) of
the species Ai. According to this chemical interpretation, x is also called con-
centration vector (Yu and Craciun, 2018). We assume that the law of mass
action holds: when two or more reactants are involved in a reaction, the reac-
tion rate is proportional to the product of their concentrations. The resulting
polynomial system of ODEs for the state variables is written as
x˙ = S v(x,k) , (1)
where the superposed dot denotes the time derivative; k = (k1, . . . , kr)
T ∈ Rr+
stands for the set of rate constants; S is the Rn×r constant stoichiometric
matrix, v(x,k) ∈ Rr+ is the vector of reaction fluxes. Here, system (1) accounts
for internal reaction and boundary fluxes (Kschischo, 2010; Schilling et al.,
2000) and hence is open (Feinberg, 1987). The matrix element Sij is the net
number of molecules of the species Ai that are produced whenever the reaction
Rj occurs. Thus the columns of S have been referred to as reaction vectors.
We are now interested in investigating the general properties of the solu-
tions of the system (1), and, in particular, in computing the corresponding
asymptotically stable states. Our study is based on the analysis of the conser-
vation laws and the stoichiometric compatibility classes of the system revised
in the next two subsections.
2.1 Conservation laws and elemental species
Definition 1 Let x(t) be a solution of the system of ODEs (1). A constant
vector γ ∈ Nn \ {0} is said to be a semi–positive conservation vector if there
exists c ∈ R+ such that
γTx(t) = c ∀t . (2)
Moreover, the relation (2) is called a semi–positive conservation law, or equiv-
alently moiety conservation law.
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Since concentrations are expressed in nM, the biochemical interpretation
of the conservation law is that the total number of molecules involved in the
species combination γTx remains constant during the evolution in time of the
network (Shinar et al., 2009). The constant total amount of available molecules
is fixed by γ and the initial state x0 through c = γ
Tx0. Moreover, the con-
centrations of the species involved in the conservation law are bounded from
above by the constant c (De Martino et al., 2014; Haraldsdo´ttir and Fleming,
2016; Shinar et al., 2009; Schuster and Ho¨fer, 1991). The following proposition
relates the conservation vectors to the properties of the stoichiometric matrix.
Proposition 1 If γ ∈ ker(ST ) ∩ Nn \ {0}, then γ is a conservation vector.
Proof The thesis follows by observing that for any solution x(t) of the system
of ODEs (1)
d
dt
(γTx) = γT x˙ = γTSv(x,k) = 0,
where the last term is equal to zero as γ ∈ ker(ST ).
We concentrate on conservation vectors γ ∈ ker(ST ). Proposition 1 implies
that the set of all possible semi–positive conservation vectors defines a convex
cone whose independent generators can be computed e.g. through the algo-
rithm proposed by Schuster and Ho¨fer (1991). In the following we will denote
with
{
γ1, . . . ,γp
}
a set of such generators and define the matrix N ∈ Rp×n as
N =
γ
T
1
...
γTp
 . (3)
Henceforth we will assume p = n− rank(S) and thus the set {γ1, . . . ,γp}
defines a basis for ker(ST )
Denote by x0 the initial point of a trajectory. Since NS = 0, it follows that
Nx(t) = Nx0 =: c (4)
is the constant vector in Rp whose components are the constants involved
in the CLs. Thus the matrix N determines p linear, independent CLs; ac-
cordingly, the representative point x(t) is constrained to move on the affine
subspace of Rn which is determined by equation (4), and hence is identified by
N and the initial data. Moreover, the linear affine subspace is the intersection
of p hyperplanes.
We conclude with a few remarks that will play a fundamental role in the
analysis of the solutions of system (1). In general, there are chemical species
that are not involved explicitly in the expressions of the CLs while the remain-
ing species may belong to more than one CL.
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Definition 2 We say that a CRN is elemented if: (i) it admits a set of gener-
ators
{
γ1, . . . ,γp
}
such that the matrix N contains at least one minor equal
to the identity matrix of order p, say Ip; (ii) each chemical species is involved
in at least one CL, i.e. for each i = 1, . . . , n there exists k ∈ {1, . . . , p} such
that γki 6= 0. If only condition (i) is fulfilled, the CRN is weakly elemented.
Borrowing the terminology of Shinar et al. (2009), the species associated
with the minor equal to the identity matrix will be called elemental or basic
species.
Remark 1 Definition 2 implies that each elemental species belongs to one, and
only one conservation law. The idea is that elemental species consist of proteins
in free form, which bind to other species involved in the same conservation law,
in order to form the derived compounds or secondary species.
In general the set of elemental species of a network is not unique as it
depends on the choice of the basis of the conservation vectors and, fixed a
basis, multiple minors equal to the identity matrix may exist.
Remark 2 Given an elemented CRN, up to a change in the order of the com-
ponents of x, the matrix N may be decomposed as
N = [Ip,N2] (5)
with N2 ∈ Rp×(n−p). Similarly, the concentration vector x may be decomposed
as
x =
(
x1
x2
)
(6)
with x1 ∈ Rp, and x2 ∈ Rn−p. In particular, x1 ∈ Rp is formed by the
elemental variables. Thus equation (4) may be rewritten in the equivalent
form
x1 = c−N2 x2 (7)
Henceforth we assume the CRN to be weakly elemented, with elemental
variables x1 ... xp, so that the matrix N is described by the block decomposition
(5).
According to (7), the set of p conservation equations is solved straight-
forwardly with respect to the elemental variables, thus yielding a parametric
description of the affine space defined in (4). Furthermore, substitution of the
expression (7) of x1 into the system (1) provides a reduced formulation of the
original system of ODEs.
Definition 3 Consider an elemented CRN. A concentration vector x ∈ Rn
is an ideal state for the network iff only the elemental species have non-zero
concentration, i.e., referring to equation (6), x2 = 0.
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2.2 Stoichiometric compatibility classes
Given the initial condition x(0) = x0, consider the corresponding solution x(t)
of the system (1), defined at least in the time domain [0, T ]. Integration in time
of both sides of (1) leads to
x(t)− x0 = S
∫ t
0
v(x(τ),k) dτ , t ∈ [0, T ]. (8)
This shows that x(t)−x0 is a linear combination of the reaction vectors, with
time-dependent coefficients. Therefore x(t) − x0 belongs to a vector space of
dimension equal to rank(S) defined by the image of the stoichiometric matrix
(Feinberg, 1987, 1995; Yu and Craciun, 2018). Accordingly, we provide the
following definition of stoichiometric compatibility class (SCC).
Definition 4 Given a value x ∈ Rn+ of the state variable for system (1), we
define a stoichiometric compatibility class (SCC) of x the set
SC(x) = (x + span(S)) ∩ Rn+ . (9)
Proposition 2 Let
{
γ1, . . . ,γp
}
be a set of generators of the the convex cone
defined by the semi–positive conservation laws and let N be the matrix defined
as in equation (5). If p = n− rank(S) then for all x ∈ Rn+
SC(x) = (x + ker(ST )⊥) ∩ Rn+ (10)
=
{
y ∈ Rn+ s.t. Ny = Nx
}
. (11)
Proof Equation (10) simply follows from Definition 4 by observing that span(S) =
(ker(ST ))⊥. Equation (11) follows from the fact that, since p = n − rank(S),
the set
{
γ1, . . . ,γp
}
is a basis for ker(ST ).
Definition 5 A CRN is said to satisfy the global stability condition if for
every stoichiometric compatibility class there exists a unique globally asymp-
totically stable state xe.
This means in particular that every trajectory with initial point on the
given SCC tends asymptotically to the steady state xe, which is also an equi-
librium point. Details about asymptotic stability properties of CRNs can be
found, e.g., in (Chellaboina et al., 2009; Feinberg, 1987; Yu and Craciun, 2018).
3 Mathematical model of Loss and Gain of Function mutations
A mutation consists essentially in a permanent alteration in the nucleotide
sequence of the genome of a cell. Mutations play a fundamental role in cancer
evolution (Stratton et al., 2009; Weinstein et al., 2013). Here we are con-
cerned with effects induced by mutations on species concentrations in the
CRN. Specifically, we consider LoF and GoF mutations that are commonly
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observed in cancer cells (Hochman et al., 2017; Lemieux et al., 2015; Levine,
2019; Levine et al., 2019).
LoF mutations result in reduction or abolishment of a protein function,
which is simulated by a restriction on the value of the related density. The
degree to which the function is lost can vary; for null mutations the function
is completely lost and the concentration of the related molecules is supposed
to vanish; for leaky mutations some function is conserved and the value of
concentration is appropriately reduced (Griffiths et al., 2005; Li et al., 2019).
In this study, we deal with null LoF mutations by referring directly to the
concentrations of the mutated molecular species, and by assuming that they
are set equal to zero.
GoF mutations are responsible for an enhanced activity of a specific pro-
tein, so that its effects become stronger (Griffiths et al., 2005; Li et al., 2019).
In our framework a GoF is implemented by excluding from our CRN the re-
actions involved in the deactivation of the considered protein; this is achieved,
by setting to zero the corresponding reaction rates.
3.1 Loss of Function
Consider a CRN described by system (1) and consider a state x of the system.
A LoF mutation of the elemental species Aj results in a projection of the state
x in a novel state where the concentrations of the j−th elemental species and
of all its compounds are zero. Equivalently, also the total concentration cj
available in the j−th conservation law is zero. This is modeled by applying
the following operator to the state x.
Definition 6 Consider an elemented CRN and let Aj be the j−th elemental
species of the network. A LoF mutation of Aj results in the operator PLj :
Rn → Rn that projects x into a novel state PLj (x) =
[
x˜T1 , x˜
T
2
]T
such that
x˜2,i =
{
0 if γji 6= 0
x2,i otherwise
, i = p+ 1, . . . , n
and
x˜1 = (c˜−N2x˜2)
where c˜ is obtained by setting to 0 the j−th element of the vector c = Nx.
Remark 3 If x is an ideal state for the CRN then PLj(x) is obtained by setting
to zero the concentration xj of the j−th elemental species.
Remark 4 PLj transforms SCCs into SCCs. Indeed, if the concentration vec-
tors x and y belong to the same SCC, i. e.
Nx = Ny = c ,
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then PLj (x) and PLj (y) still belong to the same SCC. More in details,
NPLj (x) = NPLj (y) = c˜ ,
Where c˜ is equal to c except for the j−th element that is zero.
Therefore the following theorem holds.
Theorem 1 Consider an elemented CRN described by the system of ODEs
(1), and any states x, y such that SC(x) = SC(y). Then SC(PLj (x)) =
SC(PLj (y)).
If in addition the CRN satisfies the global stability condition then the trajecto-
ries starting from PLj (x) and PLj (y) lead to the same globally asymptotically
stable state.
Remark 5 This holds in particular if x and y are replaced by the initial state
x0 and the corresponding steady state xe, respectively. Thus the trajectories
starting from PLj (x0) and PLj (xe) lead to the same mutated steady state.
3.2 Gain of Function
Consider a CRN described by system (1). In particular, let S be the stoi-
chiometric matrix of the system. A mutation resulting in the GoF of a given
protein is implemented by removing from the network the reactions involved
in the deactivation of such a protein. From a mathematical viewpoint this can
be achieved by setting to zero the values of the corresponding rate constants,
or equivalently by setting to zero the corresponding columns of S.
Definition 7 Consider a CRN and let S be the corresponding stoichiometric
matrix. Given a set of reactions identified by the indices H ⊆ {1, . . . , r} a GoF
mutation results in the operator GH : Rn×r → Rn×r that projects S into a
novel stoichiometric matrix S˜ = GH(S) such that
S˜i,h =
{
0 if h ∈ H
Si,h otherwise
, i = 1, . . . , n ,
Remark 6 GH(S) defines a new CRN where the chemical reactions in H have
been removed, while the set of chemical species, and thus the state space Rn,
are kept fixed.
Theorem 2 If the set of reactions H ⊆ {1, . . . , r} is such that
rank (GH(S)) = rank (S) (12)
then
ker
(GH(S)T ) = ker (ST ) (13)
and thus in particular the stoichiometric matrices GH(S) and S define the
same SCCs.
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Proof From Definition 7 it follows that ker
(
ST
) ⊆ ker (GH(S)T ) . Indeed, if
γ ∈ ker (ST ) then
0 = γTS =
(
γTS1, . . . ,γ
TSr
)
where Sj, j = 1, . . . , r, denotes the j−th column of S. In particular γTSj = 0
for all j = 1, . . . , r, j 6∈ H, that is γ ∈ ker (GH(S)T ).
Additionally, equation (12) implies that ker
(GH(S)T ) and ker (ST ) have
the same dimension and thus are equal.
Corollary 1 Consider a CRN described by the system of ODEs (1) and sat-
isfying the global stability condition of Definition 5. Let x and y such that
SC(x) = SC(y). If H ⊆ {1, . . . , r} is such that equation (12) holds and the
CRN having stoichiometric matrix GH(S) satisfies the stability condition then
the mutated trajectories starting from x and y lead to the same steady state.
Remark 7 This holds in particular if x and y are replaced by the initial state
x0 and the corresponding steady state xe, respectively. When considering the
CRN identified by GH(S) the trajectories starting from x0 and xe lead to the
same mutated steady state.
3.3 Concatenation of mutation
Many cancers arise by effect of a series of mutations accumulated in the cell
over time. Here we generalize the results discussed in the previous sections to
model the simultaneous action of multiple mutations on a given cell.
Consider for example a cell affected by two mutations resulting in the LoF
of the elemental species Aj1 and Aj2 . The most natural approach to quantify
the combined effect of the two mutations is to start from a concentration
vector xe modeling the (steady) state of a cell in physiological condition, and
then apply the procedure described in Section 3.1 for each single mutation one
after the other. Specifically, first we project xe through PLj1 and we compute
the steady state of the trajectory started from PLj1 (xe). Then we use PLj2 to
project the novel, mutated steady state, and we compute the trajectory started
from such a projection. The obtained trajectory will belong to the SCC{
y ∈ Rn+ s.t. Ny = c˜
}
(14)
where c˜ has been obtained by setting to zero the j1−th and the j2−th element
of c := Nxe.
The same result could have been obtained by reversing the order of the
mutations. First we project xe through Pj2 , then we apply Pj1 to the corre-
sponding steady state. The resulting trajectory will still belong to the SCC
described by equation (14) and thus will lead to the same steady state ob-
tained in the previous case, provided that the CRN satisfy the global stability
condition.
This result easily generalizes to an arbitrary set of combined GoF and LoF
mutations through the following definition.
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Definition 8 Consider an elemented CRN described by the system (1) with
stoichiometric matrix S. Consider a set of ` mutations, resulting in the LoF
of the elemental species Aj1 , . . . , Aj` , and a set of q GoF mutations, resulting
in the suppression of the sets of reactions H1, . . . ,Hq ⊆ {1, . . . , r}.
The combined effect of the considered mutations is quantified by computing
the asymptotically stable state of the system of ODEs (1) with stoichiometric
matrix
GHq ◦ · · · ◦ GH1(S) (15)
and initial condition
x(0) = PLj` ◦ · · · ◦ PLj1 (xe) (16)
where ◦ denotes function composition and xe are the values of species concen-
tration reached by the cell in physiological condition.
Theorem 3 The steady state computed through the procedure described in
Definition 8 does not depend on the order of the composition in the equations
(15) and (16) provided that
rank
(GHq ◦ · · · ◦ GH1(S)) = rank(S) (17)
and that all the involved CRNs satisfy the global stability condition of Defini-
tion 5.
Proof The thesis follows by observing that the equations (15) and (16) do not
depend on the order of the composition. Indeed the mutated stoichiometric
matrix GHq ◦ · · · ◦ GH1(S) is defined by setting to zero the columns of S corre-
sponding to the reactions in H1 ∪ · · · ∪Hq that clearly does not depend on the
order in which the GoF mutations are considered. Additionally if condition
(17) holds then GHq ◦ · · · ◦ GH1(S) and S define the same SCCs as shown in
Theorem 2. The initial condition (16) defines the unique SCC
SC(PLj` ◦ · · · ◦ PLj1 (xe)) =
{
x ∈ Rn+ s.t. Nx = c˜
}
where c˜ has been obtained from c := Nxe by setting to zero the ji−th element,
for all i = 1, . . . `. A different order of the LoF mutations results in a different
initial concentration vector on the same SCC. Therefore, according to Theorem
1 it leads to the same mutated asymptotically steady state.
Remark 8 Very recent experimental studies on cancer cells have shown the
importance of the order of mutations on the development of cancer diseases
(Levine et al., 2019). This seems to be in contrast with the results stated
in Theorem 3. However, that theorem follows from a model that does not
account for the selection process induced on the mutated cell by the external
environment. Instead, our model refers to the specific G1-S transition of a
cancerous cell and it mimics the effects of accumulated mutations just for that
phase.
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Remark 9 Coherently to the previous Remark, the process described in Defi-
nition 8 is equivalent to apply each considered mutation individually one after
the other. If the hypotheses of Theorem 3 hold, changing the order of the
mutation affects the covered trajectory but will lead to the same final steady
state.
4 Application to the colorectal cancer cells
4.1 Generalities
In this section we apply the previous procedures to the analysis of a CRN which
has been devised to provide a simplified description of how signals carried by a
ligand from outside the cell are processed in order to determine the behavior of
a CRC cell. The kinetic model applies to a healthy cell entering the G1-S phase
of its development, when a synthesis of new DNA is carried out, as a first step
in the process of cell division (Tortolina et al., 2015). Next we introduce a few
mutations that transform the healthy cell into a cancer cell, and we analyze
the related variations in the equilibrium concentrations.
We refer to the reaction network for CRC cells as CRC-CRN; its most rel-
evant features are summarized below; the full list of chemical species together
with their abbreviated names, the set of chemical reactions, the system of
ODEs, the fixed values of the rate constants, and the initial concentrations of
the elemental variables in an ideal physiologic state can be found in (Tortolina
et al., 2015), Supplementary Materials.
CRC-CRN models a specific process of signal transfer in colorectal cells. It
is activated by external signals represented by TGFβ, WNT and EGF growth
factors. Following activation, a cascade of chemical reactions proceeds. The
relevant output of the system is given by the concentrations of a number of
transcription factors (activators or repressors). CRC-CRN involves 8 constant,
and 411 varying chemical species. The constant species model non-consumable
chemicals: three constants describe the growth factors. Internal interactions
are modeled by 339 reversible and 172 irreversible reactions, for a total of
r = 850 reactions. Chemical kinetics is based on mass action law, so that 850
rate constants are considered. The state of CRC-CRN is described by n = 419
variables resulting from the concentrations of the 411 internal species, plus
8 additional variables, of null time derivative, accounting for the constant
inflows. The state variables satisfy a system of 419 polynomial ODEs as in
equation (1). In particular the monomials defining the reaction fluxes v(x,k)
are quadratic, since the reactants considered depend at most on two chemical
species. The rate constants enter the system as real and positive parameters.
4.2 Conservation laws and elemental variables of the CRC-CRN
We have obtained a basis of ker(ST ) consisting of p = 81 semi-positive con-
servation vectors, providing an independent set of 81 CLs, all of them being
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regarded as moiety CLs. In particular, we point out that CRC-CRN satisfies
the condition p = n − rank(S). As expected, 8 CLs correspond to constancy
of original non-consumable chemical species, so that they can be considered
as trivial. The remaining 73 CLs describe effective properties of the system.
It is seen by inspection that the CRC-CRN is weakly elemented, with 9
chemical species not involved in the conservation laws. Up to the 8 constant
species, the list of elemental species coincides with that of the basic species
of (Tortolina et al., 2015), which were defined as consisting of proteins in free
form, which may bind to other species in order to form derived compounds or
secondary species.
A simple, rather typical, example of conservation law within our CRC-CRN
is
NLK + NLKP + NLKP−TCFLEF + NLKP−Pase10 + TAKP−TAB−NLK = c
(18)
where c is a given constant; here NLK denotes the concentration of the ele-
mental species “Nemo like kinase” (Tortolina et al., 2015); NLPP is the phos-
phorylated form of NLK, while an expression like NLKP−TCFLEF refers to
the compound formed by NLKP and TCFLEF. Equation (18) expresses con-
servation in time of the total number of molecules of NLK belonging to the
compounds entering the combination in the left side, as discussed in §2.1. In
words, the NLK molecules are transferred between the metabolites involved
in (18), but are not synthesised, degraded or exchanged with the environment
(De Martino et al., 2014; Haraldsdo´ttir and Fleming, 2016). The constant c,
which is determined by the initial conditions, may be regarded as a counter of
the conserved molecules of NLK.
4.3 Global stability of CRC-CRN
There are a number of results available for equilibrium points and their stabil-
ity properties (Chellaboina et al., 2009; Domijan and Kirkilionis, 2008; Fein-
berg, 1995; Yu and Craciun, 2018), but they cannot be applied straightfor-
wardly to this CRC-CRN, essentially for two reasons. In fact, some of these
results require very technical hypotheses that cannot be verified in the case of
our ODEs system, due to its dimension and complexity. Further, other results
cannot be applied in the case of open systems, like the one considered in this
paper. Therefore, we will make use of numerical simulations to support the
following conjecture.
Conjecture 1 CRC-CRN satisfies the global stability condition introduced in
Definition 5.
Numerical verification. We defined 5 different SCCs by randomly selecting the
values of the total concentrations c. Specifically, each element cj , j = 1, . . . , p,
has been drawn from a log10-uniform distribution on [10
−2, 103]. For each of
the obtained SCC we generated 30 initial points
x
(k)
0 ∈
{
y ∈ Rn+ s.t. Ny = c
}
, k = 1, . . . , 30
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as follows.
– First, we dealt with the species that do not belong to any conservation law.
The value of their initial concentration were log10−uniformly drawn from
the interval [10−5, 105].
– Then we considered all the other chemical species but the elemental species.
After randomly permuting their order, for each species i:
1. we randomly selected an initial concentration value below the upper-
bound imposed by the total concentrations available in the conservation
laws involving it. More in details we set
x
(k)
0,i = u · min
j∈Γ (i)
cj
γji
,
where u was uniformly drawn from [0, 1] and
Γ (i) = {j ∈ {1, . . . , p} s.t. γji 6= 0} .
is the set of all the conservation laws involving the i−th species.
2. we updated the total concentration available in each conservation law
by removing the amount already filled by the i−th species, i.e.
cj ← cj − γji x(k)0,i
for all j ∈ Γ (i).
– Finally we considered the elemental species. By exploiting the fact that
each elemental species belongs to only one conservation law, j, we set
x
(k)
0,i = cj
where cj is the value of the total concentration still available after the
previous step.
For each of the 30 points generated with the described procedure, we used
the matlab tool ode15s (Shampine and Reichelt, 1997) to integrate the system
of ODEs (1) on the interval [0, 2.5 ·107], with initial condition x(0) = x(k)0 . The
value of the solution at the last time–point was considered as the corresponding
asymptotic steady state x
(k)
e .
Since the initial values x
(k)
0 all belong to the same SCC they should lead
to the same steady state. This was verified by computing for each species
the coefficient of variation of the equilibrium values across the 30 trajectories.
Namely, for each species we computed
εe(i) =
√
1
29
∑30
k=1(x
(k)
e,i − µe(i))2
µe(i)
(19)
where µe(i) =
1
30
∑30
k=1 x
(k)
e,i .
As a comparison, for each species we also computed the coefficient of vari-
ation ε0(i) across the initial values x
(k)
0,i , k = 1, . . . , 30.
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Fig. 1 Average and standard error of the mean over the non–constant species of the coeffi-
cient of variation across 30 different initial conditions (upper panel) and the corresponding
asymptotically stable states (lower panel). Each bar corresponds to the results obtained
with a different SCC. Note the different scale on the y axes.
Figure 1 shows the averaged coefficient of variations obtained with the 5
considered SCCs. Fixed a SCC, the coefficient of variation across the initial
values ε0 is always around 2.5, while the coefficient of variation across the
steady states εe is at least one order of magnitude lower. Moreover, the latter
shows higher differences across the SCCs. This is mainly due to the fact that
depending on the SCC, few species may require a longer time to reach the
asymptotically stable state and thus may show a higher variation when the
system of ODEs is integrated in the fixed time-interval [0, 2.5 · 107].
4.4 LoF mutation of TBRII
We investigated the impact on CRC-CNR of a mutation resulting in the LoF
of the elemental species TBRII.
First, we computed the value of the concentration vector modeling the
physiological steady state of the cell prior to mitosis. To this end, we integrated
the system of ODEs (1) on the interval [0, 2.5·107], with initial condition x(0) =
x0, where x0 is the ideal state defined by setting the initial concentrations of
the elemental species as in Tortolina et al. (2015). The value of the steady
state in the physiological cell was defined as the value of the solution at the
last time–point.
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Fig. 2 Value of the relative difference δi between the steady states in the physiological cell
and in the cell affected by LoF mutation of TBRII. Black and red lines are obtained when
the system of ODEs for the mutated cell is solved with initial condition x(0) = PLj (x0)
and x(0) = PLj (xe), respectively.
By using Definition 6, we then defined the operator PLj associated to the
LoF of TBRII. The steady state of the mutated cell was computed by inte-
grating the system of ODEs (1) with two different initial conditions, namely
x(0) = PLj (x0) and x(0) = PLj (xe). As in the previous step, in both cases we
solved the system on the interval [0, 2.5 · 107] and we defined as steady state
the value of the solution computed at the last time–point.
According to Theorem 1 the two trajectories, starting from PLj (x0) and
PLj (xe), should lead to the same steady state. This result was numerically
verified by computing for both the trajectories the relative difference
δi =
xme,i − xe,i
xe,i
, i = 1, . . . , n (20)
where xme is the steady state in the mutated cell.
As shown in Figure 2, the results obtained with the two different initial
conditions coincide and thus Theorem 1 is verified. Moreover, Figure 2 shows
the effect of the LoF of TBRII on the concentrations of all the chemical species.
Indeed, δi < 0 means that the value of the concentration of the i−th species
in the mutated cell is lower than in the healthy cell. On the contrary δi > 0
means that the amount of the i−th species is higher in the mutated cell.
On the other hand, different values of the initial conditions lead to different
trajectories. In Figure 3 we compared the time required by the two trajectories
to reach a stable state. To this end for each time point t we computed
||x˙(t)||∞ = ||Sv(x(t),k)||∞ . (21)
Since xe is already a steady state for the CRC-CRN, when computing the
projected value PLj (xe) the species not affected by the LoF of TBRII maintain
their stable values. As a consequence, the trajectory starting from PLj (xe)
requires a lower number of iterations to reach a value of ||x˙(t)||∞ closer to 0.
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Fig. 3 Infinity norm of the derivative x˙ of the concentration vector as function of time. Black
and red lines show the results obtained by solving the ODEs system (1) with initial condition
x(0) = PLj (x0) and x(0) = PLj (xe), respectively, PLj being the operator associate to the
LoF mutation of TBRII
4.5 GoF mutation of BRAF
We investigated the impact on the CRC-CNR of a mutation resulting in the
GoF of the elemental species BRAF.
To this end, following Definition 7, we defined the operator GH , where the
H is defined to include all the reactions involved in the deactivation of BRAF∗.
We recall that BRAF∗ is the activated form of BRAF, consisting in the phos-
phorylation of a specific amino acid. Thus it is assumed that the mutated form
of BRAF is still subject to activation in BRAF∗, while inactivation of BRAF∗
is blocked.
As described in Tortolina et al. (2015), Supplementary materials, the deac-
tivation of BRAF∗ is regulated by the phosphatase Pase1 through the following
set of reactions:
BRAF∗ + Pase1
k1f

k1r
BRAF∗−Pase1
BRAF∗−Pase1
k2→ BRAF + Pase1
where a simplified notation has been adopted for the rate constants. To block
such a deactivation process while respecting the condition described by equa-
tion (12) in Theorem 2 we removed the two forward reactions
BRAF∗ + Pase1
k1f→ BRAF∗−Pase1 k2→ BRAF + Pase1,
that is we defined a novel stoichiometric matrix GH(S) were the corresponding
column of S have been set equal to 0.
Similarly to what we have done in the previous section, we computed the
asymptotically stable states of the trajectories obtained solving the system of
ODEs defined by the stoichiometric matrix GH(S) with two different initial
condition, namely x(0) = x0 and x(0) = xe, x0 and xe being the ideal and
steady state for the physiological cell.
Figure 4 shows that the two trajectories lead to the same steady state as
stated in Corollary 1. Additionally, as done in the previous section, in Figure
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Fig. 4 Value of the relative difference δi between the steady states in the physiological cell
and in the cell affected by GoF mutation of BRAF. Black and red lines are obtained when
the mutated system of ODEs defined by the stoichiometric matrix GH(S) is solved with
initial condition x(0) = x0 and x(0) = xe, respectively.
Fig. 5 Infinity norm of the derivative x˙ of the concentration vector as function of time when
the stoichiometric associated to GoF of BRAF is employed in the ODEs system (1). Black
and red lines show the results obtained by setting x(0) = x0 and x(0) = xe, respectively.
5 we compare the time required by the two trajectories to reach the stable
state. According to Definition 7, the GoF of BRAF is implemented by setting
to zero a set of columns of the stoichiometric matrix S, and thus modifying the
system of ODEs associated to the CRC-CRN. Although xe was a stable state
for the system of ODEs modeling the cell in physiological condition, for most
of the species the corresponding concentration xe,i is no longer an equilibrium
value for the new system. For this reason the two trajectories, starting from xe
and x0, show similar behaviors of ||x˙(t)||∞ as function of the time t in which
the solution of the system is computed.
5 Discussion and future directions
In this paper we have considered a system of ODEs modeling a CRN, with
emphasis on the mutual relationships between moiety CLs and stoichiometric
surfaces. CLs have led to the characterization of weakly elemented CRN and
the definition of ideal states, which are crucial in the treatment of mutations.
Confining attention to systems satisfying the global stability condition, we
have considered two classes of mutations, LoF and GoF, often found in cancer
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cells. Mutations have been modeled as projection operators and basic prop-
erties of mutated networks have been analyzed, aiming at the determination
of mutated equilibrium states as asymptotic steady limits of trajectories. The
new model for mutations allows for a simple treatment of their combinations,
showing that the resulting equilibrium is independent of the order.
As an application of the previous results we have investigated a system
of ODEs describing the G1-S phase of a CRC cell. Due to the huge number
of variables involved, the analysis has been based on numerical simulations.
We have found 81 independent, linear, moiety CLs; they have been applied to
support the conjecture that CRC-CRN satisfies the global stability condition.
It has also been found that the elemental chemical species coincide with the
basic species defined by Tortolina et al. (2015) on biochemical grounds. Also,
a mutation by LoF, and another mutation by GoF have been examined in
detail.
We are aware that this computational approach to CRN is devised to cap-
ture few, although decisive, aspects of the G1-S transition point of a cell,
as well as the modifications of the network induced by cancer mutations. We
think that the model can provide a guide to future experimental research based
on the interpretation of results of simulations, particularly in the case of the
development and optimization of targeted therapies agains already mutated
cells. For example, if the simulation predicts a significant increase of the mu-
tated concentration of a specific metabolite with respect to its physiological
value, then that metabolite can be regarded as a potential drug target. More
in general, an analysis of the mutated profile of the simulated CRN in the
G1-S phase should provide hints about convenient choices of targets for avail-
able drugs, together with a framework for the simulation of their consequences
(Facchetti et al., 2012; Torres and Altafini, 2016).
Possible development of our model may involve different directions. For ex-
ample, we could extend it to examine alterations of mRNA induced by changes
from physiologic to mutated equilibrium (Castagnino et al., 2016). Further, in
the model we have not considered possible dependence of the literature data
on temperature, pH, or other conditions. Therefore, the scheme is not capa-
ble of describing the individual response of a fixed cell; rather, it attempts at
simulating the behavior of a homogeneous set of cells; from this viewpoint,
the solution of the system of ODEs may be interpreted as providing an aver-
age dynamic of the intra-cellular answer. Also, the scheme should be enriched
in order to account for the impact of the extra-cellular micro-environment,
which implies to modify the model in order to account for growth-induced
solid stresses and pressure, nutrients and oxygen supply, and blood perfusion
(Caviglia et al., 2014; Jones and Chapman, 2012; Markert and Vazquez, 2015).
As a final comment, we remark that the rate constants in the CRC-CRN
considered in this paper are assumed as known and estimated from the scien-
tific literature (Tortolina et al., 2015). A more reliable determination of these
constants can be obtained by solving a non-linear ill-posed problem (Bertero
and Piana, 2006; Engl et al., 2009) in which the input data are provided by
ad hoc conceived biochemical experiments. The setup of such experiments and
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the realization of an optimization method for the numerical solution of this
inverse problem will be part of future research.
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